{"id":64638,"date":"2026-03-20T00:10:00","date_gmt":"2026-03-19T18:40:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=64638"},"modified":"2026-03-19T17:39:28","modified_gmt":"2026-03-19T12:09:28","slug":"speciality-medicines-ipo-gmp-day-1","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/","title":{"rendered":"Speciality Medicines IPO GMP: Day 1 IPO Live Updates"},"content":{"rendered":"<p>The <strong>Speciality Medicines IPO GMP <\/strong>is \u20b90 as of 20th March 2026. It is an IPO bookbuild issue of \u20b929.14 crores. This is an entirely fresh Issue of 29.14 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 30th March 2026. The face value of Speciality Medicines IPO shares is \u20b910 per share, and the IPO price band is \u20b9117 to \u20b9124 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth \u20b92,48,000.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Speciality_Medicines_IPO_Grey_Market_Premium\" title=\"Speciality Medicines IPO Grey Market Premium\">Speciality Medicines IPO Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Speciality_Medicines_IPO_Details\" title=\"Speciality Medicines IPO Details\">Speciality Medicines IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Objectives_of_the_Speciality_Medicines_IPO\" title=\"Objectives of the Speciality Medicines IPO\">Objectives of the Speciality Medicines IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Speciality_Medicines_IPO_Registrar\" title=\"Speciality Medicines IPO Registrar\">Speciality Medicines IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Speciality_Medicines_IPO_Review\" title=\"Speciality Medicines IPO Review&nbsp;&nbsp;\">Speciality Medicines IPO Review&nbsp;&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Technical_Analysis\" title=\"Technical Analysis\">Technical Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#FAQs_on_Speciality_Medicines_IPO\" title=\"FAQs on Speciality Medicines IPO\">FAQs on Speciality Medicines IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#What_is_the_GMP_of_the_Speciality_Medicines_IPO\" title=\"What is the GMP of the Speciality Medicines IPO?\">What is the GMP of the Speciality Medicines IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#What_is_the_issue_price_of_the_Speciality_Medicines_IPO\" title=\"What is the issue price of the Speciality Medicines IPO?\">What is the issue price of the Speciality Medicines IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Who_is_the_registrar_of_the_Speciality_Medicines_IPO\" title=\"Who is the registrar of the Speciality Medicines IPO?\">Who is the registrar of the Speciality Medicines IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/speciality-medicines-ipo-gmp-day-1\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Speciality_Medicines_IPO_Grey_Market_Premium\"><\/span><strong>Speciality Medicines IPO Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of 20th March 2025, the <strong>GMP for the Speciality Medicines IPO <\/strong>stands at \u20b90.00 per share. Thus, the estimated listing price would be \u20b9146.00. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change in response to market conditions and fluctuations. Explore the table for the <strong>Speciality Medicines IPO GMP <\/strong>updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP DATE<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP Price<\/strong><\/td><td><strong>Estimated Listing Price<\/strong><\/td><td><strong>Estimated Gain<\/strong><\/td><\/tr><tr><td><strong>20-3-2026<\/strong><\/td><td>\u20b9124.00<\/td><td>\u20b90.00<\/td><td>\u20b9124.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>19-3-2026<\/strong><\/td><td>\u20b9124.00<\/td><td>\u20b90.00<\/td><td>\u20b9124.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>18-3-2026<\/strong><\/td><td>\u20b9124.00<\/td><td>\u20b90.00<\/td><td>\u20b9124.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>17-3-2026<\/strong><\/td><td>\u20b9124.00<\/td><td>\u20b90.00<\/td><td>\u20b9124.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>16-3-2026<\/strong><\/td><td>\u20b9124.00<\/td><td>\u20b90.00<\/td><td>\u20b9124.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click &amp; Sign Up to Get Latest Updates on Speciality Medicines IPO<\/em><\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Speciality_Medicines_IPO_Details\"><\/span><strong>Speciality Medicines IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>25th March 2026<\/td><\/tr><tr><td><strong>IPO Open Date<\/strong><\/td><td>20th March 2026<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>24th March 2026<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>27th March 2026<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>23,50,000 shares(agg. up to \u20b929 Cr<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,000 shares&nbsp;<\/td><\/tr><tr><td><strong>Issue Price&nbsp;<\/strong><\/td><td>\u20b9117 to \u20b9124 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>30th March 2026<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Speciality Medicines IPO<\/strong>: Speciality Medicines IPO Limited has declared an issue price band of \u20b9117 to \u20b9124 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares, each worth \u20b92,48,000. The face value of Speciality Medicines IPO Limited shares is \u20b910 per share. The shares of Speciality Medicines IPO Limited will be listed on BSE and SME on its tentative listing day, 30th March 2026. Scroll down to check GMP updates and <strong>Speciality Medicines IPO <\/strong>reviews.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Objectives_of_the_Speciality_Medicines_IPO\"><\/span><strong>Objectives of the Speciality Medicines IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Speciality Medicines IPO<\/strong> is to raise \u20b929.14 crores, and the secondary objective is to:<\/p><ul class=\"wp-block-list\"><li>The company will not receive any proceeds from the offer.<\/li>\n\n<li>Product Registration in International Markets and Product Development for sale in international markets<\/li>\n\n<li>To Meet Working Capital Requirements<\/li>\n\n<li>General Corporate Purposes<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Speciality_Medicines_IPO_Registrar\"><\/span><strong>Speciality Medicines IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Skyline Financial Services Limited is the registrar for the Speciality Medicines IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Speciality Medicines allotment and refund, you can contact Skyline Financial Services Private Limited at <a href=\"mailto:ipo@skylinerta.com\">ipo@skylinerta.com<\/a> or 02228511022.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Speciality_Medicines_IPO_Review\"><\/span><strong>Speciality Medicines IPO Review&nbsp;&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-1024x536.jpg\" alt=\"Speciality Medicines IPO Apply or Avoid\" class=\"wp-image-64639\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The <strong>Speciality Medicines IPO <\/strong>has gained neutral ratings from industry experts, brokers, and institutional investors. Speciality Medicines Limited&#8217;s revenue increased by 23.01%, from \u20b958.54 crore in March 2024 to \u20b936.93 crore in March 2025. Moreover, the company&#8217;s PAT increased by 32.52% from \u20b98.61 crore in March 2024 to \u20b96.06 crore in March 2025.<\/p><p>Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we\u2019re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for the <strong>Speciality Medicines IPO <\/strong>or not.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Analysis\"><\/span><strong>Technical Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Several technical indicators are available to assess a company&#8217;s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Speciality Medicines<strong> IPO.<\/strong><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>9.27<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>13.38<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>16.61%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>16.68%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>16.49%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>17.73%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>2.19<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9108.94<\/td><\/tr><\/tbody><\/table><\/figure><p>The P\/E ratio of Speciality Medicines Limited shares is 9.27, and its Earnings Per Share (EPS) stands at 13.38\/ Thus, the <strong>Speciality Medicines IPO<\/strong> can deliver gains on its tentative listing date, 30th March 2026.&nbsp;<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Speciality Medicines Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>9.27<\/td><td>10.49<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>13.38<\/td><td>11.82<\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or the <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Speciality_Medicines_IPO\"><\/span><strong>FAQs on Speciality Medicines IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_GMP_of_the_Speciality_Medicines_IPO\"><\/span><strong>What is the GMP of the Speciality Medicines IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Currently, on 20th March 2026, the Speciality Medicines IPO GMP (Grey Market Premium) stands at \u20b9124. This indicates that the estimated listing price could be \u20b9124.00 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_the_Speciality_Medicines_IPO\"><\/span><strong>What is the issue price of the Speciality Medicines IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Speciality Medicines IPO price range is \u20b9117 to \u20b9124 per share.\u00a0 Retail investors can apply for a minimum of 2 lot, each consisting of 2,000 shares, worth \u20b92,48,000. Moreover, HNIs are required to bid for a minimum of 15 lots (1,200 shares) worth \u20b92,06,400.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_the_Speciality_Medicines_IPO\"><\/span><strong>Who is the registrar of the Speciality Medicines IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Skyline Financial Services Limited is the registrar for the Speciality Medicines IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Speciality Medicines allotment and refund, you can contact Skyline Financial Services Private Limited at <a href=\"mailto:ipo@skylinerta.com\">ipo@skylinerta.com<\/a> or 02228511022.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Speciality Medicines IPO, download the Speciality Medicines IPO RHP and Speciality Medicines IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"http:\/\/univest.in\/blogs\/novus-loyalty-ipo-gmp-day-3;\"><strong>Novus Loyalty IPO GMP Day 3<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/novus-loyalty-ipo-subscription-status-day-3\"><strong>Novus Loyalty IPO Subscription Status Day 3<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/rajputana-stainless-ipo-listing-preview\"><strong>Rajputana Stainless IPO Listing Preview<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/innovision-ipo-listing-preview\"><strong>Innovision IPO Listing Preview<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Speciality Medicines IPO GMP is \u20b90 as of 20th March 2026. It is an IPO bookbuild issue of \u20b929.14 crores. This is an entirely fresh Issue of 29.14 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 30th March 2026. The face value of Speciality Medicines IPO<\/p>\n","protected":false},"author":28,"featured_media":64640,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1015,1352],"class_list":["post-64638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo","tag-ipo-gmp"],"metadata":{"_edit_lock":["1773922195:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:87:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/03\/Speciality-Medicines-Apply-or-Avoid.jpg\";a:2:{s:2:\"id\";i:64639;s:11:\"source_type\";s:13:\"media-library\";}s:96:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/03\/Speciality-Medicines-Apply-or-Avoid-1024x536.jpg\";a:2:{s:2:\"id\";i:64639;s:11:\"source_type\";s:13:\"media-library\";}s:119:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid.jpg\";a:2:{s:2:\"id\";i:64639;s:11:\"source_type\";s:13:\"media-library\";}s:128:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172555\/Speciality-Medicines-Apply-or-Avoid-1024x536.jpg\";a:2:{s:2:\"id\";i:64639;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["68"],"rank_math_description":["The status of the Speciality Medicines IPO GMP day 1. Discover the IPO Price, Date, Subscription Status, Grey Market Premium GMP, Allotment, Listing Date, and Review. Read more!\n"],"rank_math_title":["Speciality Medicines IPO GMP Day 1 | Click to Check Live Updates"],"rank_math_focus_keyword":["Speciality Medicines IPO GMP Day 1"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["64640"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/19172629\/Speciality-Medicines-GMP-Day-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/64638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=64638"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/64638\/revisions"}],"predecessor-version":[{"id":64641,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/64638\/revisions\/64641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/64640"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=64638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=64638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=64638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}